Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human AKAP12 ELISA Kit (AC3819)
Cat.#: ASET-2408
Specifications
Description Human AKAP12 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human AKAP12 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.59 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-2517 Mouse GAPDH ELISA Kit (AC3928) Quantitative inquiry ASET-1787 Human UCP3 ELISA Kit (AC3198) Quantitative inquiry ASET-1583 Chicken Adiponectin ELISA Kit (AC2994) Quantitative inquiry ASET-1186 Human TRPC5 ELISA Kit (AC2597) Quantitative inquiry ASET-1833 Human Ferritin Heavy Chain ELISA Kit (AC3244) Quantitative inquiry ASET-1974 Rat p75 NGF Receptor ELISA Kit (AC3385) Quantitative inquiry ASET-2467 Human Attractin ELISA Kit (AC3878) Quantitative inquiry ASET-2068 Mouse LIF ELISA Kit (AC3479) Quantitative inquiry ASET-1173 Mouse Wnt8b ELISA Kit (AC2584) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket